(Q43279568)

18 November 2017

Pharmacological inhibition of the hypertensive response to combretastatin A-4 phosphate in rats (English)

1 reference

18 November 2017

Qingen Ke

1

1 reference

18 November 2017

Natalya Bodyak

2

1 reference

18 November 2017

Debra L Rigor

3

1 reference

18 November 2017

Nicole W Hurst

4

1 reference

18 November 2017

David J Chaplin

5

1 reference

18 November 2017

Peter M Kang

6

1 reference

18 November 2017

6 September 2009

1 reference

18 November 2017

Vascular Pharmacology

1 reference

18 November 2017

51

1 reference

18 November 2017

5-6

1 reference

18 November 2017

337-343

1 reference

Assessment of pharmacodynamic vascular response in a phase I trial of combretastatin A4 phosphate

18 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.004

Cardiovascular safety profile of combretastatin a4 phosphate in a single-dose phase I study in patients with advanced cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.004

Combretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.004

Endothelial function as a determinant of vascular function and structure: a new therapeutic target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.004

Effect of pretreatment with atenolol and nifedipine on ZD6126-induced cardiac toxicity in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.004

In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.004

Interactions of combretastatin, a new plant-derived antimitotic agent, with tubulin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.004

Regulation of endothelin-1 gene expression by cell shape and the microfilament network in vascular endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.004

Isolation and structure of the human cancer cell growth inhibitory cyclodepsipeptide dolastatin 16

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.004

Phase I clinical trial of weekly combretastatin A4 phosphate: clinical and pharmacokinetic results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.004

Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.004

Mouse cardiac surgery: comprehensive techniques for the generation of mouse models of human diseases and their application for genomic studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.004

Medicinal chemistry of combretastatin A4: present and future directions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.004

Combretastatin A4 phosphate: background and current clinical status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.08.004

10.1016/J.VPH.2009.08.004

7 January 2021

Identifiers

DOI

1 reference

release_d3qxi4ty7nannihv7nk3oixqzy

18 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/d3qxi4ty7nannihv7nk3oixqzy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference